Xeloda Oral, Trastuzumab, and Pertuzumab Combined Drug Therapy Reduced Cervical Lymphadenopathy and Dermal Involvement in Patient With Recurrent Breast Cancer: Case Report

• Главные авторы: Victor Manuel Saure Sarría (Автор), Ariel D. Arencibia PhD (Автор), Vívian D'Afonseca PhD (Автор)
• Формат: ‌
• Опубликовано: SAGE Publishing, 2020-07-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

We report the case of a 42-year-old woman who was diagnosed with breast cancer that recurred 3 years later, with supraclavicular lymphadenopathy and dermal involvement. The main drug used in the therapy was trastuzumab; however, the association of this drug with docetaxel was not able to decrease or...